Core Insights - The forum on "AI-driven Disease Prevention Innovation and Health Economics Value" was held in Beijing, organized by the China Artificial Intelligence Industry Development Alliance (AIIA) Medical AI Committee, highlighting the collaboration between Beijing United Family Hospital and Alibaba DAMO Academy [1][2] - The partnership aims to leverage DAMO Academy's "One Scan, Multiple Checks" AI technology to provide multi-disease screening services, focusing on digestive tumors and chronic diseases [1][2] Group 1 - The collaboration will enhance early detection and precise diagnosis of digestive tumors through the establishment of a digestive tumor center at Beijing United Family Hospital [1] - DAMO Academy's "One Scan, Multiple Checks" technology has successfully addressed screening challenges for pancreatic and gastric cancers, with results published in top international journals and recognized by the FDA as a "breakthrough medical device" [1] Group 2 - The partnership will also address the challenges posed by an aging population and rising chronic disease incidence, utilizing "CT + AI" for monitoring osteoporosis, severe fatty liver, and cardiovascular diseases [2] - The hospital's president emphasized a patient-centered approach, integrating AI with medical care to advance health management for cancer and chronic diseases [2]
和睦家与阿里达摩院达成战略合作,推动消化肿瘤、慢性病AI筛查